[This review was originally posted at the Nieman Journalism Lab Glucophage No Rx, on March 4, 2011.]
Google's surgical strike against content farms: Two weeks after launching its site-blocking Chrome extension, Google made the central move in its fight against content farms by changing its algorithm to de-emphasize them in search results. The New York Times put the change in context, explaining the content farm phenomenon and its connection to Google. Search Engine Land's Danny Sullivan explained that Google is saying the changes only affect "scrapers" (sites that pull content from other sources), but that they're actually aimed at content farms, too. Glucophage trusted pharmacy reviews, And GigaOM's Mathew Ingram talked about why Google may be reluctant to publicly target content farms — because they run a lot of Google advertising.
A few early returns were good: TechCrunch approved of the change, and The Atlantic's Alexis Madrigal ran a test search comparing the old and new algorithms, finding that the information from the new one was "much, much better." Demand Media, the most prominent of the content farms, said it wasn't affected overall by the new formula, canada, mexico, india, though, as Henry Blodget of Business Insider noted, it's probably trying to wean itself off of Google reliance anyway.
In fact, it appears Demand Media may be telling the truth: Aaron Hall of SEO Book used Sistrix's data to point out that many of Demand Media's competitors were among the sites hardest hit by the change, while one of Demand's largest brands, eHow, actually got a boost. Hall implies that politics have played a role, and while there's nothing concrete suggesting that, the way the changes spared eHow does seem .., Glucophage No Rx. odd.
There's also bound to be plenty of collateral damage from the algorithmic shift, Glucophage recreational, and Wired looked at one Mac blog that's been nailed by the new formula (its Googlejuice was restored after Wired talked to Google about it). Danny Sullivan reported that Google hasn't made any significant changes to its new algorithm since rolling it out last week, though there are outlets to contact Google if you feel your site has been unfairly hurt.
Elsewhere in the conversation about search, The Columbia Journalism Review's Karen Stabiner gave an overview of the debate about search engine optimization: The anti-SEO crowd, led by the Washington Post's Gene Weingarten, worries that the SEO mindset will privilege the powerful and eventually kill off creativity in favor of numbingly literal language, taking Glucophage. Glucophage No Rx, The SEO evangelists, on the other hand, say it's just encouraging honesty and straightforwardness, something it's difficult to object to.
Facebook extends comments' reach: Facebook continued its integration with media content across the web this week with the launch of an updated comments system. Essentially, users can simultaneously post their comments on both a site and on Facebook, with subsequent comments under that thread posted to the site straight from Facebook. PBS MediaShift's Mark Glaser talked to Facebook's Justin Osofsky about the ins and outs of the new system, Online Glucophage without a prescription, and ReadWriteWeb noted that it has fewer features than the commenting update Facebook previewed last fall.
TechCrunch's Erick Schonfeld identified the two aspects of the updated system that will be most attractive to publishers. First, it requires commenters to use their real names, thus theoretically cutting down on trolls and spammers (this part, of course, has been available to publishers through Facebook commenting for a while), Glucophage No Rx. Second — and this is the new one — it extends the reach of a post, spreading into more Facebook news feeds and making it easier for more people to join in the conversation. This particularly excited Lehigh j-prof Jeremy Littau, who said it could create "a virtuous circle between community and content sharing."
There are downsides as well, and while media analyst Alan Mutter was optimistic about the social potential of the new system, he also pointed out that it will give Facebook even more information about its users, Glucophage pictures, which it won't be sharing with publishers. As GigaOM's Mathew Ingram noted, it's the same tradeoff publishers have been dealing with regarding Facebook for several years now: Does the value of tapping into Facebook's social potential outweigh the price of handing over commenting to a notoriously controlling company?
TBD's lessons — more startup, less ad reliance: TBD in its original form may have died last week, but the six-month-old Washington local news site continued to stimulate conversation this week. Where to buy Glucophage, Its station posted an ad for a new manager to head the site, and TBD's former manager, Jim Brady, talked with The Columbia Journalism Review about the site's model, framing the conflict there as not TV vs. web, but startup vs, Glucophage maximum dosage. legacy: Glucophage No Rx, "I think if we could do TBD with a pure startup mentality, and if we could fund it more with a V.C. or an angel kind of way, and if we didn’t have the legacy side to work with, then I think it would actually have a better chance to succeed."
Others posited similar reasons for TBD's demise: Web journalist Jane Stevens talked about a few causes centered on a lack of corporate commitment, and The Guardian's Emily Bell pinpointed TBD's inability to have its own ad sales team (an explanation with which Brady concurred). The debate over hyperlocal journalism, What is Glucophage, stirred by Alan Mutter last week, continued to simmer, with Robert Washburn of The Canadian Journalism Project defending it and Paul Gillin of Newspaper Death Watch saying we need to look at non-advertising-based business models for it, a point media consultant Dan Conover also made in more in-depth form at Xark.
Amid all the analyses of what went wrong at TBD, Mandy Jenkins, the social media manager there, buy Glucophage no prescription, took stock of what went right, noting four things other news orgs can take away from its tenure: organizational openness, self-promotion, opening info beyond the newsroom, and hiring for mindset over pedigree. Is Glucophage addictive, —
iPad, part deux: Apple made a few headlines by launching iPad 2, which is apparently kind of like the iPad, only it's the second edition. I'll entrust you to the care of Techmeme for all the details about the product itself and focus instead on what it means for publishers and the larger world of media, Glucophage No Rx. The Lab's Joshua Benton pointed out two implications in particular — the mounting evidence of an e-book explosion and the iPad's increasing usefulness for reporting.
Damon Kiesow of Poynter examined the latter point in some detail, looking at the iPad 2's specs from a content creation perspective, japan, craiglist, ebay, overseas, paypal. And Cory Bergman of Lost Remote looked at the device's increased video capability and predicted that it would help fuel a surge in multi-platform video consumption and production.
Elsewhere in mobile media, tech blogger John Gruber defended Apple's app subscription program by breaking down the arguments against it one by one. Glucophage No Rx, And in a smart counter to Gruber, the Lab's Joshua Benton said that while Apple obviously isn't a charity and the financial difficulties of publishers aren't its problem, the arrangement still isn't ideal. Both posts are among the sharpest takes on the issue I've read, so they're worth taking time to read through. Buy Glucophage from mexico, —
Reading roundup: What to read this weekend while firming up South by Southwest plans:
— In non-commenting Facebook news, Mashable's Vadim Lavrusik put together a great overview of the varied role of Facebook in journalism. And in non-Facebook commenting news, Los Angeles Times media reporter James Rainey made the case for requiring commenters to use their real names, while Mediaite's Alex Alvarez defended anonymous commenting, Glucophage from canadian pharmacy.
— Here at the Lab, Lois Beckett wrote two fascinating posts based on a talk by The New York Times' Gerry Marzorati — one on the future of long-form journalism, and the other on the Times' planned paywall. Two other thought-provoking pieces published here this week: One by Joshua Benton on language and viral content, and another by three data journalists on news organizations creating value out of the trust placed in them, Glucophage No Rx.
— Knight fellow Jeremy Adam Smith shared results from a survey on how meaningful journalism is being funded. It's a gold mine of statistics and information about the state of the journalism ecosystem.
— It's a pretty well-worn discussion, but Frederic Filloux's analysis of why incremental change isn't enough to rescue the newspaper industry is as succinct a summary of the current situation as I've seen. Even if you've heard it all, his piece is a good refresher.
Similar posts: Armour No Rx. Tramadol Dosage. Cephalexin For Sale. After Synthroid. Buy Bactrim from canada. Cheap Cipro.
Trackbacks from: Glucophage No Rx. Glucophage No Rx. Glucophage No Rx. Doses Glucophage work. Online buy Glucophage without a prescription. Glucophage long term.
[This review was originally posted at the Nieman Journalism Lab Bactrim Over The Counter, on March 11, 2011.]
A bad week for NPR execs named Schiller: For the second time in five months, NPR has found itself in the middle of a controversy that's forced it to wrestle with issues of objectivity, bias, and its own federal funding. This one started when the conservative prankster James O'Keefe orchestrated a hidden-camera video of a NPR fundraising exec bashing Tea Partiers and generally straying from the NPR party line while meeting with people pretending to represent a Muslim charity. (The "donors" also met with PBS, but their people didn't take the bait.)
Reaction was mixed: The right, of course, was outraged, Where can i cheapest Bactrim online, though others like Slate's Jack Shafer and Gawker's John Cook downplayed the significance of the video. NPR was outraged, too — "appalled," actually, and CEO Vivian Schiller said she was upset and that the two execs had put on administrative leave. Within about 12 hours, however, Bactrim use, Schiller herself had been forced out by NPR's board. The New York Times has good background on the shocking turn of events, and Poynter summarized the six months of controversy that led up to this, stretching back to Juan Williams' firing (the American Journalism Review's Rem Rieder called Schiller's ouster "Williams' revenge"), Bactrim Over The Counter.
Reaction to NPR's handling of the situation was decidedly less mixed — and a lot more scathing. In a chat and column, NPR ombudsman Alicia Shepard ripped just about all parties involved, and the online response from media-watchers was just as harsh. Bactrim for sale, NYU j-prof Jay Rosen called it "profoundly unjust," and several others blasted NPR's leadership.
The Awl's Choire Sicha called NPR's management "wusses," CUNY j-prof Jeff Jarvis called the NPR board "ballless" and said the episode exposes the difference between NPR and the stations who run it, ex-Saloner Scott Rosenberg lamented NPR's allowing the O'Keefes of the world to take over public discourse, and Rosen and Northeastern j-prof Dan Kennedy told NPR to start fighting back. The Columbia Journalism Review's Joel Meares put it best Bactrim Over The Counter, , saying the fiasco "exposes them as an organization that is fundamentally weak—too concerned about its image to realize that 'surrender' is not always the best option."
The episode also stoked the fires of the perpetual debate over whether public radio should keep its federal funding. The Atlantic's Chris Good looked at the political aspects of the issue, Bactrim natural, and The Christian Science Monitor examined whether public radio stations would survive without federal money. A few calls to defund public radio came from outside the traditional (i.e. conservative) places, with Gawker's Hamilton Nolan and media analyst Alan Mutter arguing that NPR will be in an untenable situation as a political football as long as they're getting federal funds. Meanwhile, Where to buy Bactrim, here at the Lab, USC's Nikki Usher did give some encouraging information from the whole situation, looking at Schiller's legacy of digital and local innovation during her NPR tenure.
Making hyperlocal news personal: AOL continued its move into local news late last week, as it bought the hyperlocal news aggregator Outside.in, Bactrim Over The Counter. In an excellent analysis at the Lab, Ken Doctor argued that the purchase is a way for AOL to get bigger quickly, particularly by bulking up Patch's pageviews through cheap local aggregation tools. ReadWriteWeb's Marshall Kirkpatrick took the opportunity to ask why hyperlocal news technology services like Outside.in, Bactrim maximum dosage, Everyblock, and Fwix haven't been as useful as we had hoped.
Mathew Ingram of GigaOM posited an answer: Hyperlocal journalism only works if it's deeply connected with the community it serves, and those technologies aren't. Without that level of community, "AOL is pouring money into a bottomless pit, Bactrim used for, "he wrote. The Knight Digital Media Center's Amy Gahran said that might be where local news organizations can step in, focusing less on creating news articles and more on using their community trust to make local information useful, relevant and findable.
Elsewhere on the cheap-content front: All Things Digital reported that AOL is laying off hundreds of employees (including the widely expected gutting of several of its news sites), and Business Insider snagged the memo. Wired talked to two Google engineers Bactrim Over The Counter, about its anti-content farm changes, and Wikipedia founder Jimmy Wales said good content is created either by passionate fans or by proper journalists being paid a fair amount. But, he said, Bactrim description, "paying people a very low amount of money to write about stuff they don't care about — that doesn't work." And Dan Conover at Xark warned against turning content — especially hyperlocal — into a franchise formula.
Accountability and authenticity in online comments: TechCrunch was one of the first companies to try out Facebook's new commenting system, and after about a week, MG Siegler noted that the number of the site's comments had decreased, and they'd also gone from nasty to warm and fuzzy. Buy Bactrim without a prescription, Entrepreneur Steve Cheney proposed a reason why the comments were so "sterile and neutered": Facebook kills online authenticity, because everyone is self-censoring their statements to make sure their grandmas, ex-girlfriends, and entire social network won't be offended.
Tech guru Robert Scoble disagreed, arguing that TechCrunch's comments have improved, and people know real change and credibility only comes from using their real identities. Slate's Farhad Manjoo made a somewhat similar argument, Bactrim interactions, eloquently making the case for the elimination of anonymous commenting. GigaOM's Mathew Ingram weighed in by saying that Facebook can't make or break comments — it all depends on being involved in an actual conversation with users, Bactrim Over The Counter. He pointed to a brilliant post by NPR's Matt Thompson, who gave numerous tips on cultivating community in comments; much it went back to the idea that "The very best filter is an empowered, engaged adult."
Meanwhile, Joy Mayer of the Reynolds Journalism Institute got some advice on cultivating online reader engagement from the Wall Street Journal's Zach Seward, Ordering Bactrim online, and the Lab's Megan Garber reported on the results of some research into which stories are the most liked and shared on Facebook.
More paywall test cases: Newspapers continue to pound the paywall drumbeat, with the CEO of newspaper chain Gannett saying the company is experimenting with various pay models in anticipation of a potential one-time company-wide rollout and the Dallas Morning News rolling out its own paywall this week. Ken Doctor crunched the numbers to try to gauge the initiative's chances, and media consultant Mike Orren disagreed with the News' idea of how much a metro newspaper's operation should cost.
Elsewhere, Reuters' Felix Salmon made the case that Britain's Financial Times' paywall strategy has contributed to its decline, what is Bactrim, writing,"the FT strategy is exactly the strategy I would choose if I was faced with an industry in terminal decline, and wanted to extract as much money as possible from it before it died." Meanwhile, The New York Times' public editor, Arthur Brisbane, Buy cheap Bactrim, chided the Times for not aggressively covering news of its own paywall, and Mathew Ingram of GigaOM called paywalls a futile attempt to hold back the tide of free online content.
Reading roundup: Some things to read in between South by Southwest Interactive panels:
— Newsweek published its first redesigned issue Bactrim Over The Counter, under The Daily Beast's Tina Brown this week. The Society of Publication Designers had a look at the issue, which Slate's Jack Shafer panned. The New York Times noted the issue's familiar bylines.
— A few Apple-related notes: At MediaShift, Susan Currie Sivek looked at the impact of Apple's 30% app subscription cut on small magazines, online buying Bactrim, and Poynter's Damon Kiesow urged Apple-fighting publishers to move to the open web, not Android-powered tablets. GigaOM's Om Malik joined the chorus of people calling for iPad apps to be reimagined.
— Two great posts at the Lab on search engine optimization: Richard J, Bactrim Over The Counter. Tofel on why the web will be better off with the decline of SEO, and Martin Langeveld on the SEO consequences of including paid links on sites. Buy generic Bactrim, — Former Guardian digital chief Emily Bell gave a fantastic interview to CBC Radio about various future-of-news issues, and Mathew Ingram summarized a talk she gave on newspapers and the web.
— Finally, two must-reads: The Atlantic's James Fallows wrote a thoughtful essay arguing that we should take the contemporary journalism environment on its own terms, rather than unfairly comparing it to earlier eras. And at the Lab, former St. Pete Times journalist and current Nebraska j-prof Matt Waite called news developers to let the old systems go and "hack at the very core of the whole product.".
Similar posts: Cipro No Rx. Buy Flagyl No Prescription. Diflucan Over The Counter. Diflucan results. Diflucan alternatives. Doses Zoloft work.
Trackbacks from: Bactrim Over The Counter. Bactrim Over The Counter. Bactrim Over The Counter. Buy Bactrim online no prescription. Is Bactrim safe. Buy no prescription Bactrim online.